Market closed·Syncing…
Market closed · Close · 19 Nov

Laxmi Dental Limited LAXMIDENTLshare price and chart

Laxmi Dental closed at ₹192.56 on 19 November 2026, down 1.45% on the day. The 52-week range is ₹155.88 to ₹308.45.

₹192.56The price one share last traded at, in rupees.▼ 1.45% · ₹2.83
52-wk low ₹15624% up the rangeThe highest and lowest price the share has traded at in the past year, and where today's price sits between the two.high ₹308

Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.

Loading prices…

Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.

Test a strategy on LAXMIDENTL

Real prices, every charge counted. Pick one or write your own.
What Laxmi Dental Limited does
A short, human-reviewed summary of the business, written from public sources. Background, not analysis, and not updated intraday.
business summary

Laxmi Dental markets brands across restorative, orthodontic, dental material, paediatric and digital dentistry categories, including dentist-prescribed aligners and aligner materials and equipment, and runs mass media campaigns to build awareness of dental products.

1
1Sector

Healthcare Equipment & Supplies

2
2What it sells

Restorative and orthodontic products, aligners, dental materials

Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.

EOD 19 Nov
RSI (14) · 30 oversold, 70 overboughtA score from 0 to 100 showing how strong recent up days were against recent down days.
48.4Neutral
0 oversold3070overbought 100
Delivery · bought to hold vs churnOf all the shares traded in a day, the share that actually changed hands and went into someone's demat account, rather than being bought and sold the same day.
65.7%Near average
today 65.7%20d avg 56.6%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50 DMAHow far today's close is above or below the average closing price of the last 50 trading days. It shows the medium-term trend.+0.0%vs 200 DMAHow far today's close is above or below the average closing price of the last 200 trading days, about ten months. It is the most watched line for the long-term trend.▼ 4.5%1 monthHow much the share price has changed over the period.+8.2%3 monthsHow much the share price has changed over the period.▼ 1.6%1 yearHow much the share price has changed over the period.▼ 38.1%Vol 30dHow much the share has actually been moving day to day, stated as a yearly percentage. 30% means it swung roughly 30% a year at that pace.36.2%

Returns and valuationWhat the market pays for this company and how well the business uses its money.

Books to 30 Sept 2026
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.₹1,060 Cr19 NovP/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.32.7xlast 4 quarters, to Sept 2026Return on equityHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.12.8%full year FY26Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.4.00xbooks of Sept 2026Return on capitalHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.13.1%full year FY26EV / EBITDAWhat it would cost to buy the whole company, against the cash profit its business makes in a year. It is a P/E that ignores how the company is financed.22.4xDividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.0.00%last 12 monthsDebt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.00xbooks of Sept 2026FCF marginOf every ₹100 of sales, how much cash was left after running the business and paying for new assets.-7.7%year to Mar 2026

Against its sectorWhere this company ranks among similar companies on each measure.

Medical Equipment & Supplies · 16 peers · medians
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.32.69vs 32.55 median
Cheapest: GKB 6.05Priciest: TARSONS 215.39
Net marginOf every ₹100 of sales, how much is left as profit after all costs, interest and tax.11.01%vs 4.31% median
Lowest: MHHL -4.14%Highest: AVIENCE 17.16%
Revenue growthHow much sales grew in the latest quarter against the same quarter a year earlier.10.04%vs 20.84% median
Lowest: FABTECH -24.2%Highest: NURECA 55.08%

What the numbers sayShort plain statements about this company's latest figures.

Written by fixed rules

Latest quarterIn the quarter to September 2026 (results filed 3 Nov 2026), sales rose 10.0% from a year earlier to ₹79.5 cr and profit rose 17.6% to ₹10.0 cr.

Going well
  • No borrowings at the FY26 balance sheet.
Worth watching
  • Operations used cash in FY26 (-₹5.0 cr) while reported profit was ₹28.9 cr.
Also changed
  • Foreign institutions cut their holding by 27.0 points over 5 quarters (33.59% to 6.58%).
  • Domestic institutions cut their holding by 3.6 points over 5 quarters (14.31% to 10.68%).

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

Share price reaction to resultsWhat the share price did around each recent quarterly result.

Over the last 8 results, the share rose on 3 and fell on 5, and moved by 3% or more on 6.

+23%
-23%
Q4 FY25Q3 FY26Q2 FY27

Q2 FY27: results filed 3 Nov 2026. The share went from its close on 2 Nov 2026 to its close on 4 Nov 2026 +4.70%.

What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.

Price only, before dividends
-34.3%over the last year
1 yr
-34.3%

Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.

Who owns it
41.75%promoter holding, as of 2026-09-30+0.0 pts since 2025
Promoter share since listing
2025-0141.75% now, drawn to its own range2026-09
Who owns it todayas of Sep 26
41.8%
41.0%
Promoter41.8%Foreign (FII)6.6%Domestic (DII)10.7%Public & others41.0%
Who is buying, who is leavingJun 25 to Sep 26
Promoter41.8%steady
Foreign (FII)6.6%-27.0 pts
Domestic (DII)10.7%-3.6 pts

Each line is that holder's share of all shares over the last 6 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.

The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.

Insider tradesPurchases and sales of the company's own shares by promoters, directors and senior staff.

Last 18 months
Buy
SAMEER KAMLESH MERCHANT
Promoters · 01-Apr-2026 12:23
17,179 sh
₹27.4 L
Buy
SAMEER KAMLESH MERCHANT
Promoters · 28-Feb-2026 11:38
15,000 sh
₹28.5 L
Buy
RAJESH VRAJLAL KHAKHAR
Promoters · 23-Feb-2026 18:58
11,000 sh
₹21.2 L
Buy
RAJESH VRAJLAL KHAKHAR
Promoters · 21-Feb-2026 19:07
12,000 sh
₹23.3 L
Buy
RAJESH VRAJLAL KHAKHAR
Promoters · 21-Feb-2026 19:07
12,000 sh
₹23.3 L

Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.

Last 6 months
Analysts/Institutional Investor Meet/Con. Call Updates07-Nov-2026

Laxmi Dental Limited has informed the Exchange about Transcript

Copy of Newspaper Publication05-Nov-2026

Laxmi Dental Limited has informed the Exchange about Copy of Newspaper Publication

Updates04-Nov-2026

Laxmi Dental Limited has informed the Exchange regarding 'Receipt of EU Quality Management System Certificate under Regulation (EU) 2017/745 on Medical Devices and ISO 13485:2016 Certificate by Kids-e-Dental LLP, a jointly controlled entity of the Company'.

Analysts/Institutional Investor Meet/Con. Call Updates04-Nov-2026

Laxmi Dental Limited has informed the Exchange about Link of Recording

Press Release03-Nov-2026

Laxmi Dental Limited has informed the stock exchange regarding a press release dated 03rd November, 2026 titled Intimation of Press Release

Investor Presentation03-Nov-2026

Laxmi Dental Limited has informed the Exchange about Investor Presentation

Outcome of Board Meeting03-Nov-2026

Laxmi Dental Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Analysts/Institutional Investor Meet/Con. Call Updates28-Oct-2026

Laxmi Dental Limited has informed the Exchange about Schedule of meet

General Updates21-Oct-2026

Laxmi Dental Limited has informed the Exchange about General Updates

Effect(s) on listed entity due to changed regulatory framework applicable21-Oct-2026

Laxmi Dental Limited has informed the Exchange about Effect(s) on listed entity due to changed regulatory framework applicable

Analysts/Institutional Investor Meet/Con. Call Updates10-Oct-2026

Laxmi Dental Limited has informed the Exchange about Schedule of meet

Monitoring Agency Report08-Oct-2026

Monitoring Agency Report for quarter ended September 30, 2026

Updates08-Oct-2026

Laxmi Dental Limited has informed the Exchange regarding 'Board Comments On The Fine Levied By The NSE And BSE'.

General Updates08-Oct-2026

Laxmi Dental Limited has informed the Exchange about General Updates

Certificate under SEBI (Depositories and Participants) Regulations, 201808-Oct-2026

Laxmi Dental Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Backtest idea · LAXMIDENTLMACD momentum

Momentum turning up, only while the long trend is up.

BuyMACD crosses above signal, price above 200-day SMA
SellMACD crosses back below
Real prices · every charge countedRun on LAXMIDENTL
Backtest idea · LAXMIDENTLLower band bounce

Buys a stretch below the usual range, sells on the way back.

BuyCloses below the lower Bollinger band
SellBack at the middle band, or 15 days
Real prices · every charge countedRun on LAXMIDENTL
Backtest idea · LAXMIDENTLSupertrend rider

Stays in while the trend line says up, out when it flips.

BuySupertrend turns up
SellSupertrend turns down
Real prices · every charge countedRun on LAXMIDENTL
Your own ideaWrite a rule for LAXMIDENTL in plain English“Buy LAXMIDENTL when …”
Start writing
Buy the dip on LAXMIDENTLBuy when RSI(14) drops below 30
52-week high breakout on LAXMIDENTLBuy when closes at a 52-week high
Golden cross on LAXMIDENTLBuy when 50-day EMA crosses above 200-day
Stochastic oversold on LAXMIDENTLBuy when stochastic %K drops below 20
Pullback in an uptrend on LAXMIDENTLBuy when RSI(14) below 40, price above 200-day EMA

Key ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.

Against its sector
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.
₹1,060 cr
Larger than 75% of 16 peers
sector middle ₹429 cr
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.
32.7x
Around the middle of 12 peers
sector middle 32.5x
Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.
4.0x
Higher than 79% of 14 peers
sector middle 2.3x
ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.
12.8%
Highest of 5 peers
sector middle 8.1%
FY25 15.3%FY26 12.8%
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.
13.1%
Higher than 58% of 12 peers
sector middle 11.4%
FY25 16.9%FY26 13.1%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.
0.00
No borrowings
sector middle 0.20
FY25 0.05FY26 0.00
Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
0.0%
Lower than 38% of 16 peers
sector middle 0.0%
Sales growthHow much sales grew in the latest quarter against the same quarter a year earlier.
+10.0%
Lower than 67% of 9 peers
sector middle +20.8%

Peers are the listed companies in the exchange's own industry group: Medical Equipment & Supplies. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

Cash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.

Where the cash went

In FY26 cash fell by ₹101 Cr, after ₹16 Cr spent on plant and equipment.

FY26Cash in or out
Running the business-₹5 Cr
Investing-₹80 Cr
Lenders and shareholders-₹18 Cr
Net change in cash-₹101 Cr
Operating cash per ₹100 of profit
₹138FY25₹-17FY26
₹100 or more means the reported profit arrived as cash.

Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.

MeasureFY25FY26
ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.15.3%12.8%
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.16.9%13.1%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.05x0.00x

Each row against this company's own usual level: green better, red worse, grey close to it.

Backtest idea · LAXMIDENTLStochastic oversold

Buys when the close sits near the bottom of its recent range.

BuyStochastic %K drops below 20
Sell8% profit, or after 15 days
Real prices · every charge countedRun on LAXMIDENTL
Backtest idea · LAXMIDENTLPullback in an uptrend

Buys a pause inside a rising trend.

BuyRSI(14) below 40, price above 200-day EMA
Sell8% profit, or after 30 days
Real prices · every charge countedRun on LAXMIDENTL
Backtest idea · LAXMIDENTLBuy the dip

Buys after a sharp fall, betting on a bounce.

BuyRSI(14) drops below 30
Sell10% profit, or after 20 days
Real prices · every charge countedRun on LAXMIDENTL
Backtest idea · LAXMIDENTL52-week high breakout

Buys strength, when the price makes a new one-year high.

BuyCloses at a 52-week high
Sell8% stop loss
Real prices · every charge countedRun on LAXMIDENTL
Backtest idea · LAXMIDENTLGolden cross

Follows the long trend: in when the fast average crosses above the slow one.

Buy50-day EMA crosses above 200-day
SellWhen it crosses back below
Real prices · every charge countedRun on LAXMIDENTL
MACD momentum on LAXMIDENTLBuy when MACD crosses above signal, price above 200-day SMA
Lower band bounce on LAXMIDENTLBuy when closes below the lower Bollinger band
Supertrend rider on LAXMIDENTLBuy when supertrend turns up
Buy the dip on LAXMIDENTLBuy when RSI(14) drops below 30
52-week high breakout on LAXMIDENTLBuy when closes at a 52-week high

Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.

Medical Equipment & Supplies
CompanyWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.How much operating profit the company made on all the money in the business, whether it came from owners or lenders.Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.Of every ₹100 of sales, how much is left as profit after all costs, interest and tax.How much sales grew in the latest quarter against the same quarter a year earlier.The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
MOLBIO
Molbio Diagnostics Limited
17,590 cr-12.2x--0.22--0.00%
POLYMED
Poly Medicure Limited
16,933 cr53.2x5.2x10.8%13.7%0.1214.8%+30.8%0.21%
TARSONS
Tarsons Products Limited
1,616 cr215.4x2.5x2.3%4.5%0.611.6%+20.8%0.00%
FISCHER
Fischer Medical Ventures Limited
1,496 cr87.9x3.2x8.1%11.5%0.114.3%+24.5%0.22%
LAXMIDENTL
Laxmi Dental Limited
1,060 cr32.7x4.0x12.8%13.1%0.0011.0%+10.0%0.00%
QLINE
Q-Line Biotech Limited
952 cr12.8x2.0x-19.5%0.2715.4%-0.00%
DENTALKART
Vasa Denticity Limited
840 cr69.7x4.4x-9.1%0.003.8%-0.00%
FABTECH
Fabtech Technologies Limited
593 cr15.7x1.4x9.1%11.3%0.079.2%-24.2%0.45%
OSELDEVICE
Osel Devices Limited
527 cr23.8x2.3x-23.9%0.649.5%-0.34%
QMSMEDI
QMS Medical Allied Services Limited
331 cr-3.6x--0.86--0.29%
NURECA
Nureca Limited
285 cr60.7x1.5x1.1%3.3%0.012.7%+55.1%0.00%
APRAMEYA
Aprameya Engineering Limited
238 cr-------0.00%
MADHAVBAUG
Vaidya Sane Ayurved Laboratories Limited
162 cr41.3x2.3x-16.9%0.183.4%+17.5%0.00%
AVIENCE
Avience Biomedicals Limited
138 cr12.2x2.2x-23.2%0.4417.2%-0.00%
MHHL
Mohini Health & Hygiene Limited
49 cr-0.5x--9.9%1.62-4.1%+50.2%0.00%
GKB
GKB Ophthalmics Limited
30 cr6.0x----3.2%+8.5%0.00%
GML
Galaxy Medicare Limited
26 cr8.7x0.6x-11.2%0.107.1%+7.8%4.15%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.

Month by month
YearJanFebMarAprMayJunJulAugSepOctNovDecYear
2026
-30.6
+1.9
-17.8
+25.7
+16.9
-3.2
-5.5
-8.1
-2.1
-7.2
+8.4
·
-29.3%
11m
2025
·
-31.3
+31.2
-12.0
-2.0
+13.2
-2.9
-19.1
-4.7
-3.4
-11.8
-1.7
-44.8%
11m
Monthly movebelow -10%-10 to -5-5 to -2-2 to 00 to +2+2 to +5+5 to +10above +10%month in progress

Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.

Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.

DatePartySideQuantityPriceValue
2026-02-19NK SECURITIES RESEARCH PRIVATE LIMITED · bulkSELL5,26,205₹203.11₹10.69 Cr
2026-02-19NK SECURITIES RESEARCH PRIVATE LIMITED · bulkBUY5,26,205₹202.93₹10.68 Cr
2025-09-17GRAVITON RESEARCH CAPITAL LLP · bulkBUY6,82,079₹361.45₹24.65 Cr
2025-09-17GRAVITON RESEARCH CAPITAL LLP · bulkSELL6,82,079₹360.98₹24.62 Cr
2025-09-17HRTI PRIVATE LIMITED · bulkBUY4,28,476₹360.14₹15.43 Cr
2025-09-17HRTI PRIVATE LIMITED · bulkSELL4,15,826₹360.88₹15.01 Cr
2025-09-17JUNOMONETA FINSOL PRIVATE LIMITED · bulkSELL3,56,223₹361.11₹12.86 Cr
2025-09-17JUNOMONETA FINSOL PRIVATE LIMITED · bulkBUY3,56,223₹360.92₹12.86 Cr
Annual reports

The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.

Read enough? Test LAXMIDENTL. “Buy LAXMIDENTL when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.

Run it free